NASDAQ · KVACW

Keen Vision Acquisition Corporation

$0.02 -$0.00 (-9.09%) 1D Market open

Key Metrics

Market cap
P/E · TTM
Revenue · TTM
$1.43M
Net income
EPS · TTM
Dividend yield
Free cash flow
Beta · 1Y -2.72
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 15
    The stock moved +60.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 15
  • May 22
    From its Feb 13 high, the share price fell 92%.

    Peak close $0.13 on Feb 13; trough close $0.01 on May 22. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -92%
  • Apr 29
    The stock moved +147.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 29

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.01 – $0.14
Avg volume · 20D52.7K
Net cash
Book value / share
IndustryBlank Checks
ExchangeNASDAQ
About Keen Vision Acquisition Corporation
IPO dateSep 15, 2023
Employees

Keen Vision Acquisition Corp is a blank check company.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -24.8% · —

Financial Health

Current ratio0.02
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital−$4.37M

Cash Flow · TTM

Operating CF −$745.04K
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings